Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

17 results
Display

How to Identify Patients at Risk of Silent Atrial Fibrillation after Cryptogenic Stroke: Potential Role of P Wave Dispersion

Acampa M, Lazzerini , Martini G

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Blood Pressure Management for Stroke Prevention and in Acute Stroke

Hong KS

Elevated blood pressure (BP) is the leading modifiable risk factor for stroke and the benefit of BP lowering therapy on the stroke risk reduction is well established. The optimal BP...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Audiovestibular Loss of a Vascular Cause: A Distinction Should Be Made between Cochlear and Vestibular Symptoms

Pirodda A, Raimondi M, Brandolini C

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Acute Ischemic Stroke in Nonconvulsive Status Epilepticus–Underestimated? Results from an Eight-Year Cohort Study

Traenka C, Marchis GM, Hert L, Seiffge DJ, Polymeris , Peters N, Bonati LH, Engelter S, Lyrer P, Rüegg S, Sutter R

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Factors Influencing Oral Anticoagulant Prescribing Practices for Atrial Fibrillation

Leung LY, McAllister M, Selim M, Fisher M

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Endovascular Therapy: The Second Round Begins

Lee JS, Hong KS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Thrombectomy in Acute Ischemic Stroke: Challenges to Procedural Success

Yoo AJ, Andersson

The overwhelming clinical benefit of intra-arterial stroke therapy owes to the major advance in revascularization brought on by the current generation of thrombectomy devices. Nevertheless, there remains a sizeable proportion...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Response to Letter by Dr. Cristina Brandolini

Kim HA, Lee H

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Causes and Solutions of Endovascular Treatment Failure

Kim BM

In a meta-analysis of individual patient data from 5 randomized controlled trials, endovascular treatment (EVT) mainly using a stent retriever achieved successful recanalization in 71.1% of patients suffering from acute...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Emerging Roles of microRNAs in Ischemic Stroke: As Possible Therapeutic Agents

Khoshnam S, Winlow W, Farbood Y, Moghaddam , Farzaneh M

Stroke is one of the leading causes of death and physical disability worldwide. The consequences of stroke injuries are profound and persistent, causing in considerable burden to both the individual...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Family History and Stroke Risk in China: Evidence from a Large Cohort Study

Tian T, Jin G, Yu C, Lv J, Guo Y, Bian Z, Yang L, Chen Y, Shen H, Chen Z, Hu Z, Li L, China Kadoorie Biobank Collaborative Group

BACKGROUND AND PURPOSE: Large cohort studies on relationship between family history of stroke (FHS) and stroke risk are lacking in Asians. We aimed to systematically evaluate the association of FHS...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association of Optimal Combination Drug Treatment with Obesity Status among Recent Ischemic Stroke Patients: Results of the Vitamin Intervention for Stroke Prevention (VISP) Trial

Park JH, Lee J, Ovbiagele

BACKGROUND AND PURPOSE: One explanation for the ‘obesity paradox’, where obese patients seem to have better cardiovascular outcomes than lean patients, is that obese patients display an identifiable high cardiovascular...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Nationwide “Hospital Emergent Capability Accreditation by Level-Stroke” Improves Stroke Treatment in Taiwan

Cheng TJ, Peng GS, Jhao WS, Lee JT, Wang TH

BACKGROUND AND PURPOSE: Recombinant tissue plasminogen activator (rtPA) is one of the proven therapies that improve the outcome of patients with acute ischemic stroke (AIS). In 2009, the Ministry of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Blood Pressure May Be Associated with Arterial Collateralization in Anterior Circulation Ischemic Stroke before Acute Reperfusion Therapy

Jiang B, Churilov L, Kanesan L, Dowling R, Mitchell P, Dong Q, Davis S, Yan B

BACKGROUND AND PURPOSE: Leptomeningeal collaterals maintain arterial perfusion in acute arterial occlusion but may fluctuate subject to arterial blood pressure (ABP). We aim to investigate the relationship between ABP and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Diagnostic and Therapeutic Strategies for Acute Intracranial Atherosclerosis-related Occlusions

Lee JS, Hong JM, Kim JS

Intracranial atherosclerosis-related occlusion (ICAS-O) is frequently encountered at the time of endovascular revascularization treatment (ERT), especially in Asian countries. However, because baseline angiographic findings are similar between ICAS-O and embolism-related...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Simple Estimates of Symptomatic Intracranial Hemorrhage Risk and Outcome after Intravenous Thrombolysis Using Age and Stroke Severity

Lee HJ, Lee JS, Choi JC, Cho YJ, Kim BJ, Bae HJ, Kim DE, Ryu WS, Cha JK, Kim DH, Nah HW, Choi KH, Kim JT, Park MS, Hong JH, Sohn SI, Kang K, Park JM, Kim WJ, Lee J, Shin DI, Yeo MJ, Lee KB, Kim JG, Lee SJ, Lee BC, Oh MS, Yu KH, Park TH, Lee J, Hong KS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Multidisciplinary Approach to Decrease In-Hospital Delay for Stroke Thrombolysis

Jeon SB, Ryoo SM, Lee DH, Kwon SU, Jang S, Lee EJ, Lee SH, Han JH, Yoon MJ, Jeong S, Cho YU, Jo S, Lim SB, Kim JG, Lee HB, Jung SC, Park KW, Lee MH, Kang DW, Suh DC, Kim JS

BACKGROUND AND PURPOSE: Decreasing the time delay for thrombolysis, including intravenous thrombolysis (IVT) with tissue plasminogen activator and intra-arterial thrombectomy (IAT), is critical for decreasing the morbidity and mortality of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr